Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine‐needle aspiration

BACKGROUND: The transcription factors ARX and PDX1, and alternative lengthening of telomeres (ALT) were recently described as prognostic markers for resected non‐functional pancreatic neuroendocrine tumors (PanNETs). ALT positive tumors with ARX expression relapse most often. Currently, tumor size i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diagn Cytopathol
Main Authors: Hackeng, Wenzel M., Morsink, Folkert H. M., Moons, Leon M. G., Heaphy, Christopher M., Offerhaus, G. Johan A., Dreijerink, Koen M. A., Brosens, Lodewijk A. A.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7079001/
https://ncbi.nlm.nih.gov/pubmed/31846235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dc.24368
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados